Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Howard M. Julien"'
Autor:
William T. Wang, Anne Hellkamp, Jacob A. Doll, Laine Thomas, Ann Marie Navar, Gregg C. Fonarow, Howard M. Julien, Eric D. Peterson, Tracy Y. Wang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 3 (2018)
BackgroundThe 2013 American College of Cardiology/American Heart Association cholesterol guidelines recommend high‐intensity statins for patients after myocardial infarction (MI) rather than treating to a low‐density lipoprotein cholesterol goal,
Externí odkaz:
https://doaj.org/article/a39fa29882854876933f046b9dbcb36b
Publikováno v:
Medical Clinics of North America. 106:401-409
A modern approach to mitigating the impact of cardiovascular disease on Americans demands not only an understanding of modifiable conditions that contribute to its development but also a greater appreciation of the heterogeneous distribution of these
Autor:
Maxwell Ambrosino, Sydney Emerson, Lauren Catalano, Erik Hossain, Howard M. Julien, Douglas S. Jacoby
Publikováno v:
The American journal of cardiology. 190
Lipid-lowering therapies are an established cornerstone of secondary prevention. For patients with clinical atherosclerotic cardiovascular disease, guidelines provide a class I recommendation for high-intensity statins. Furthermore, patients with low
Autor:
Monika Sanghavi, Elizabeth Packard, Santina Sperling, Lauren A. Eberly, Marietta Ambrose, Howard M. Julien, Adi Hirshberg, Sri Adusumalli, Jennifer Lewey
Publikováno v:
PloS one. 17(10)
Postpartum cardiovascular (CV) evaluation of women with preeclampsia is recommended to screen for and treat modifiable risk factors to reduce lifetime CV risk. However, attendance at in-person postpartum obstetric and cardiology clinic visits is low.
Autor:
Ashwin S. Nathan, Kriyana P. Reddy, Lin Yang, Lauren A. Eberly, Elias J. Dayoub, Sameed A. M. Khatana, Howard M. Julien, Nimesh D. Desai, Wilson Y. Szeto, Howard C. Herrmann, Taisei J. Kobayashi, Paul Fiorilli, Wayne B. Batchelor, Roxana Mehran, Mohamad Adnan Alkhouli, Jay Giri, Peter W. Groeneveld, Alexander C. Fanaroff
Publikováno v:
JAMA Cardiology. 8:120
ImportanceRacial and ethnic minority and socioeconomically disadvantaged patients have been underrepresented in randomized clinical trials. Efforts have focused on enhancing inclusion of minority groups at sites participating at clinical trials; howe
Autor:
Lauren A. Eberly, Lin Yang, Utibe R. Essien, Nwamaka D. Eneanya, Howard M. Julien, Jing Luo, Ashwin S. Nathan, Sameed Ahmed M. Khatana, Elias J. Dayoub, Alexander C. Fanaroff, Jay Giri, Peter W. Groeneveld, Srinath Adusumalli
Publikováno v:
JAMA Health Forum
Key Points Question Are there inequities in glucagon-like peptide-1 receptor agonist (GLP-1 RA) use based on race, ethnicity, sex, and socioeconomic status among patients with diabetes in the US? Findings This 5-year cohort study of 1 180 260 commerc
Autor:
Sameed Ahmed M. Khatana, Lin Yang, Lauren A. Eberly, Howard M. Julien, Srinath Adusumalli, Peter W. Groeneveld
Publikováno v:
PloS one. 17(6)
Telemedicine utilization increased significantly in the United States during the COVID-19 pandemic. However, there is concern that disadvantaged groups face barriers to access based on single-center studies. Whether there has been equitable access to
Autor:
Mary Elizabeth Deleener, Srinath Adusumalli, Howard M. Julien, Sameed Ahmed M. Khatana, Ashwin S. Nathan, Christopher K. Snider, Lauren A. Eberly
Publikováno v:
Circulation
Autor:
Lauren A, Eberly, Monika, Sanghavi, Howard M, Julien, Laura, Burger, Neel, Chokshi, Jennifer, Lewey
Publikováno v:
JAMA Network Open. 5:e2144255
Autor:
Nihar R, Desai, Jacob A, Udell, Yongfei, Wang, Erica S, Spatz, Kumar, Dharmarajan, Tariq, Ahmad, Howard M, Julien, Amarnath, Annapureddy, Abhinav, Goyal, James A, de Lemos, Frederick A, Masoudi, Deepak L, Bhatt, Karl E, Minges, Harlan M, Krumholz, Jeptha P, Curtis
Publikováno v:
Circulation. Cardiovascular quality and outcomes. 12(3)
Background Despite improvements on individual process of care measures for acute myocardial infarction (AMI), little is known about performance on a composite measure of AMI care that assesses the delivery of many components of high-quality AMI care.